Concentra (CON) Q3 2026 Earnings Call Transcript
Concentra (CON) reported Q3 2026 revenue of $622.1M, up 8.6% YoY, and net income of $67.8M, up 36%. Adjusted EBITDA rose 17.9% to $140.2M. The company raised full-year revenue and EBITDA guidance. It opened seven new centers and authorized a $250M share repurchase program. Management noted risks including moderating organic growth and uncertainty in workers' compensation rates for 2027.
How this was made
The 30-second read
Why it matters
Earnings beat and guidance raise provide a fresh catalyst for traders; the leadership change and debt reduction plan add nuance.
Market read
Strong quarterly performance and raised outlook position CON for potential upside in the near term.
What to watch
Higher debt level ( $1.52B ) and leverage ratio 2.9x may limit upside if rates rise.
Background
Concentra Group Holdings Parent, Inc. reported its Q3 2026 results, highlighted leadership transition, and announced a new $250M share repurchase authorization.
Ticker impact
Q3 2026 earnings released with revenue $622.1M (+8.6% YoY) and net income $67.8M (+36%), plus raised full‑year guidance.
likely upward move as market prices in better-than-expected results and higher guidance
Revenue and earnings both exceeded expectations, margins expanded, and guidance was increased, providing a clear catalyst for buying.
Market effects
Healthcare services sector may see modest rally on improved occupational health demand.
U.S. market may see slight gain in health‑services indices.
Limited to U.S. investors; no direct global macro effect.
Counterpoint
If the guidance raise is already priced in, the stock could face short‑term profit‑taking.
Key entities
- companyConcentra Group Holdings Parent, Inc.
U.S. occupational health services provider (ticker CON).
